Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	8,077	8,524	4,477	10,325	2,399
Short-Term Investments	3	0	0	0	0
Cash & Cash Equivalents	8,080	8,524	4,477	10,325	2,399
Cash Growth	-5.21%	90.40%	-56.64%	330.39%	14.08%
Receivables	8,221	8,115	7,977	5,741	4,349
Inventory	5,088	5,634	5,051	4,029	3,370
Other Current Assets	3,200	2,956	2,608	1,862	1,775
Total Current Assets	24,589	25,229	20,113	21,957	11,893
Property, Plant & Equipment	9,448	9,280	8,333	5,912	4,749
Goodwill and Intangibles	60,690	58,638	62,037	38,726	39,728
Other Long-Term Assets	3,999	4,007	4,640	2,457	2,011
Total Long-Term Assets	74,137	71,925	75,010	47,095	46,488
Total Assets	98,726	97,154	95,123	69,052	58,381
Accounts Payable	2,872	3,381	2,867	2,175	1,920
Deferred Revenue	2,689	2,601	2,655	1,271	916
Current Debt	3,609	5,579	2,537	2,628	676
Other Current Liabilities	4,842	5,449	5,377	4,230	2,685
Total Current Liabilities	14,012	17,010	13,436	10,304	6,197
Long-Term Debt	31,308	28,909	32,333	19,107	17,076
Other Long-Term Liabilities	6,682	7,203	8,499	5,124	5,433
Total Long-Term Liabilities	37,990	36,112	40,832	24,231	22,509
Total Liabilities	52,002	53,122	54,268	34,535	28,706
Total Debt	34,917	34,488	34,870	21,735	17,752
Debt Growth	1.24%	-1.10%	60.43%	22.44%	-6.52%
Retained Earnings	47,364	41,910	35,431	28,116	22,092
Comprehensive Income	-3,224	-3,099	-2,329	-2,807	-2,679
Shareholders' Equity	46,735	43,978	40,793	34,507	29,675
Net Cash / Debt	-26,837	-25,964	-30,393	-11,410	-15,353
Net Cash Per Share	-69.17	-65.90	-76.56	-28.60	-38.10
Working Capital	10,577	8,219	6,677	11,653	5,696
Book Value Per Share	121.08	112.19	103.54	87.14	74.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).